The Higher Expression of CDCA2 Associated with Poor Prognosis in Glioma.

Jin, Xin; Sun, Zhen-Qing; Zhou, Gui-Liang; Li, Guo-Jun; Deng, Shi-Feng

Jin, Xin; Sun, Zhen-Qing; Zhou, Gui-Liang; Li, Guo-Jun; Deng, Shi-Feng.

Affiliation

Jin X; Department of Neurosurgery, Guangdong 999 Brain Hospital, Guangzhou, Guangdong, China.
Sun ZQ; Department of Neurosurgery, Guangdong 999 Brain Hospital, Guangzhou, Guangdong, China.
Zhou GL; Department of Bioinformation, Guangdong South China New Drug Development Center, Guangzhou, Guangdong, China.
Li GJ; Department of Neurosurgery, Guangdong 999 Brain Hospital, Guangzhou, Guangdong, China.
Deng SF; Department of Neurosurgery, Guangdong 999 Brain Hospital, Guangzhou, Guangdong, China.

Dis Markers ; 2022: 2184867, 2022.

Article in En | MEDLINE | ID: mdl-35386230

Subject(s)

Brain Neoplasms; Glioma; Brain Neoplasms/genetics; Carrier Proteins/metabolism; Cell Cycle Proteins/genetics; Cell Cycle Proteins/metabolism; Chromosomal Proteins, Non-Histone/genetics; Chromosomal Proteins, Non-Histone/metabolism; Glioma/genetics; Glioma/pathology; Humans; Nuclear Proteins/metabolism; Polycomb Repressive Complex 1/metabolism; Prognosis

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Glioma Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Dis Markers Journal subject: BIOQUIMICA Year: 2022 Document type: Article Affiliation country: China Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google